These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17587738)

  • 1. Molecular basis of thromboembolism in association with atrial fibrillation.
    Yamashita T
    Circ J; 2007; 71 Suppl A():A40-4. PubMed ID: 17587738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism and risk factors of cardiogenic thromboembolism in patients with atrial fibrillation].
    Otsuka T
    Nihon Rinsho; 2013 Jan; 71(1):36-40. PubMed ID: 23631169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prothrombotic state in atrial fibrillation: pathophysiological and management implications.
    Khan AA; Lip GYH
    Cardiovasc Res; 2019 Jan; 115(1):31-45. PubMed ID: 30388199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of thromboembolism in acute atrial fibrillation or atrial flutter.
    Stoddard MF
    Echocardiography; 2000 May; 17(4):393-405. PubMed ID: 10979012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients.
    Bukowska A; Hammwöhner M; Corradi D; Mahardhika W; Goette A
    Herzschrittmacherther Elektrophysiol; 2018 Mar; 29(1):76-83. PubMed ID: 29234866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of left and right atrial 3D hemodynamics in patients with atrial fibrillation: a 4D flow MRI study.
    Markl M; Carr M; Ng J; Lee DC; Jarvis K; Carr J; Goldberger JJ
    Int J Cardiovasc Imaging; 2016 May; 32(5):807-15. PubMed ID: 26820740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C; Barrios V; Jimenez D
    Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.
    Kamel H; Okin PM; Longstreth WT; Elkind MS; Soliman EZ
    Future Cardiol; 2015 May; 11(3):323-31. PubMed ID: 26021638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When the body and appendage of the left atrium disagree: "Focal" atrial fibrillation-implications for atrial thrombus formation and risk of thromboembolism.
    Seto TB; Buchholz WA; Douglas PS; Manning WJ
    J Am Soc Echocardiogr; 1999 Dec; 12(12):1097-100. PubMed ID: 10588786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Ding WY; Gupta D; Lip GYH
    Heart; 2020 Oct; 106(19):1463-1468. PubMed ID: 32675218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocardial Changes in Nonvalvular Atrial Fibrillation Without Atrial Thrombus-Thrombomodulin and Tissue Factor Pathway Inhibitor.
    An K; Mei J; Zhu J; Tang M
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1148-1152. PubMed ID: 29364003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of thromboembolism in new onset or transient atrial fibrillation.
    Stoddard MF
    Prog Cardiovasc Dis; 1996; 39(1):69-80. PubMed ID: 8693097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to left atrial appendage exclusion: the WATCHMAN device.
    Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT
    Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation.
    Shimizu H; Murakami Y; Inoue S; Ohta Y; Nakamura K; Katoh H; Sakne T; Takahashi N; Ohata S; Sugamori T; Ishibashi Y; Shimada T
    Stroke; 2002 Apr; 33(4):1005-10. PubMed ID: 11935052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
    Zabalgoitia M; Halperin JL; Pearce LA; Blackshear JL; Asinger RW; Hart RG
    J Am Coll Cardiol; 1998 Jun; 31(7):1622-6. PubMed ID: 9626843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental?
    Setiabudi E; Alwi I; Setiati S
    Acta Med Indones; 2008 Jan; 40(1):40-7. PubMed ID: 18326899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo.
    Fatkin D; Kelly RP; Feneley MP
    J Am Coll Cardiol; 1994 Mar; 23(4):961-9. PubMed ID: 8106703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of development of thromboembolic complications in patients with atrial fibrillation].
    Zotova IV; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2013; 53(3):72-80. PubMed ID: 23548430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.